Holen Sie sich die Stockscreener-App
0.1102
0.27%
0.0003
Schlusskurs vom Vortag:
$0.1099
Offen:
$0.112
24-Stunden-Volumen:
246.87K
Relative Volume:
0.44
Marktkapitalisierung:
$5.43M
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
-1.61%
1M Leistung:
-7.32%
6M Leistung:
-84.26%
1J Leistung:
-90.82%
1-Tages-Spanne:
$0.1005
$0.112
1-Wochen-Bereich:
$0.0962
$0.1136
52-Wochen-Spanne:
$0.095
$1.7194
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Firmenname
Cellyan Biotechnology Co Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
0.1102 | 5.43M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
1,004.84 | 117.15B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
340.92 | 65.06B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
254.06 | 58.83B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.38 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.35 | 1.16B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd Aktie (HKPD) Neueste Nachrichten
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - The Globe and Mail
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - TipRanks
Cellyan Biotechnology (NASDAQ: HKPD) Announces Extraordinary Meeting on September 21, 2026 for Share Consolidation Proposal - Kalkine Media
12 Industrials Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Cellyan Biotechnology Calls September 21 EGM to Approve 1-for-20 Share Consolidation - TipRanks
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - marketscreener.com
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - benzinga.com
12 Industrials Stocks Moving In Tuesday's After-Market Session - benzinga.com
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - FinancialContent
12 Industrials Stocks Moving In Tuesday's Intraday Session - benzinga.com
JYD Stock Price, Quote & News - Syfe
Click Files up to $100 Million Mixed Shelf - Yahoo Finance
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 ResistanceMA Cross Alert - vinanet.vn
Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement - Yahoo Finance
SunCar Technology Group Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Compliance Deficiency - Yahoo Finance
Kam Leung Chan Net Worth (2026) - GuruFocus
These stocks have an unusual volume in today's session - ChartMill
Jingyan Wu Net Worth (2026) - GuruFocus
Shu Liu Net Worth (2026) - GuruFocus
Chenyu Andy Liang Net Worth (2026) - GuruFocus
Zifeng Wang Net Worth (2026) - GuruFocus
Mike Yao Zhou Net Worth (2026) - GuruFocus
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
What's going on in today's pre-market session - ChartMill
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Cellyan Biotechnology Wins Second Nasdaq Grace Period to Fix Sub-$1 Share Price - TipRanks
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule - marketscreener.com
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com Nigeria
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Thursday's after hours session: top gainers and losers - ChartMill
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance | HKPD Stock News - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Ohmyhome Ltd Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Finance
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - Yahoo Finance
Cellyan Biotech (HKPD) Holds Steady Near Support After Minor DeclineMA Cross Alert - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility PersistsBox Spread - dars.gov.et
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39Channel Projection - newsline.com
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39New Listing Stocks - newsline.com
Finanzdaten der Cellyan Biotechnology Co Ltd-Aktie (HKPD)
Es liegen keine Finanzdaten für Cellyan Biotechnology Co Ltd (HKPD) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
7.72%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):